Zobrazeno 1 - 10
of 186
pro vyhledávání: '"Mohamed H. Zaki"'
Publikováno v:
IEEE Open Journal of Vehicular Technology, Vol 5, Pp 1073-1087 (2024)
Autonomous vehicles (AVs) represent a transformative advance in automotive technology, promising increased safety and efficiency by reducing human error. However, integrating human factors remains a critical challenge, especially during takeover scen
Externí odkaz:
https://doaj.org/article/4afc2c1ba10c4d1ca6902a281dacf38a
Publikováno v:
IEEE Open Journal of Vehicular Technology, Vol 5, Pp 606-619 (2024)
Traffic conflict techniques enable a comprehensive assessment of traffic safety analysis. Formal methods allow the identification of factors that contribute to traffic safety issues and provide evidence of potential safety degradation. As such, forma
Externí odkaz:
https://doaj.org/article/d2d554db9cbd4fe3a01f512f86a9ee6c
Publikováno v:
IEEE Open Journal of Intelligent Transportation Systems, Vol 4, Pp 456-470 (2023)
The paper proposes a generative pedestrian trajectory modeling framework named HISS - Human Interactions in Shared Space. The trajectory modeling framework is based on a receding horizon optimization approach utilizing pedestrian behavior and interac
Externí odkaz:
https://doaj.org/article/635364fcbb424a8fa8fbebb592843d79
Publikováno v:
IEEE Access, Vol 10, Pp 81624-81641 (2022)
Urbanization is bringing together various modes of transport, and with that, there are challenges to maintaining the safety of all road users, especially vulnerable road users (VRUs). There is a need for street designs that encourages cooperation bet
Externí odkaz:
https://doaj.org/article/8ddd063f49ff48e68c37ae753dce780c
Publikováno v:
IEEE Access, Vol 8, Pp 27291-27307 (2020)
Next-generation transportation will be integrated, interconnected and highly autonomous. One key challenge in traffic management is ensuring safety while maintaining the required level of service quality. In such future mobility systems, rigorous for
Externí odkaz:
https://doaj.org/article/02c292e90f07495b823e687fef31842f
Autor:
Katja C. Weisel, Meletios A. Dimopoulos, Philippe Moreau, Martha Q. Lacy, Kevin W. Song, Michel Delforge, Lionel Karlin, Hartmut Goldschmidt, Anne Banos, Albert Oriol, Adrian Alegre, Christine Chen, Michele Cavo, Laurent Garderet, Valentina Ivanova, Joaquin Martinez-Lopez, Stefan Knop, Xin Yu, Kevin Hong, Lars Sternas, Christian Jacques, Mohamed H. Zaki, Jesus San Miguel
Publikováno v:
Haematologica, Vol 101, Iss 7 (2016)
Pomalidomide + low-dose dexamethasone is effective and well tolerated for refractory or relapsed and refractory multiple myeloma after bortezomib and lenalidomide failure. The phase III trial MM-003 compared pomalidomide + low-dose dexamethasone with
Externí odkaz:
https://doaj.org/article/fa867e0b751047269a953f3a7844514a
Autor:
Jesus F. San Miguel, Katja C. Weisel, Kevin W. Song, Michel Delforge, Lionel Karlin, Hartmut Goldschmidt, Philippe Moreau, Anne Banos, Albert Oriol, Laurent Garderet, Michele Cavo, Valentina Ivanova, Adrian Alegre, Joaquin Martinez-Lopez, Christine Chen, Christoph Renner, Nizar Jacques Bahlis, Xin Yu, Terri Teasdale, Lars Sternas, Christian Jacques, Mohamed H. Zaki, Meletios A. Dimopoulos
Publikováno v:
Haematologica, Vol 100, Iss 10 (2015)
Pomalidomide is a distinct oral IMiD® immunomodulatory agent with direct antimyeloma, stromal-support inhibitory, and immunomodulatory effects. The pivotal, multicenter, open-label, randomized phase 3 trial MM-003 compared pomalidomide + low-dose de
Externí odkaz:
https://doaj.org/article/01073b8b38a44d4986806589d588c09e
Autor:
Meletios A. Dimopoulos, Katja C. Weisel, Kevin W. Song, Michel Delforge, Lionel Karlin, Hartmut Goldschmidt, Philippe Moreau, Anne Banos, Albert Oriol, Laurent Garderet, Michele Cavo, Valentina Ivanova, Adrian Alegre, Joaquin Martinez-Lopez, Christine Chen, Andrew Spencer, Stefan Knop, Nizar J. Bahlis, Christoph Renner, Xin Yu, Kevin Hong, Lars Sternas, Christian Jacques, Mohamed H. Zaki, Jesus F. San Miguel
Publikováno v:
Haematologica, Vol 100, Iss 10 (2015)
Patients with refractory or relapsed and refractory multiple myeloma who no longer receive benefit from novel agents have limited treatment options and short expected survival. del(17p) and t(4;14) are correlated with shortened survival. The phase 3
Externí odkaz:
https://doaj.org/article/098a6e1ecfe649c8ae8d56fc2fba2b0d
Publikováno v:
Journal of Intelligent Transportation Systems. :1-15
Publikováno v:
Transportmetrica A: Transport Science. :1-27